PHARMA NORD ApS — Credit Rating and Financial Key Figures

PHARMA NORD ApS (CVR number: 67303016) is a company from HADERSLEV. The company reported a net sales of 447.4 mDKK in 2023, demonstrating a growth of 1.8 % compared to the previous year. The operating profit percentage was at 3.9 % (EBIT: 17.6 mDKK), while net earnings were 23.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was 7.9 %, which can be considered decent but Return on Equity (ROE) was 13.6 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 37.6 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. PHARMA NORD ApS's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.